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Abstract 
It has been recently claimed that it is possible to predict the rate of de novo 
mutation of each site in the human genome with almost perfect accuracy 
(Michaelson et al. (2012) Cell, 151, 1431-1442). We show that this claim is 
unwarranted. By considering the correlation between the rate of de novo 
mutation and the predictions from the model of Michaelson et al., we show 
that there could be substantial unexplained variance in the mutation rate. We 
also demonstrate that the model of Michaelson et al. fails to capture a major 
component of the variation in the mutation rate, that which is local but not 
associated with simple context. 
 
Article 
It has been known for some time, from comparative studies, that the mutation 
rate varies at a number of different scales along the human genome, from 
variation between individual nucleotides, to differences between whole 
chromosomes (Hodgkinson and Eyre-Walker, 2011). Much of this variation 
has remained unexplained (Hodgkinson and Eyre-Walker, 2011). However, 
Michaelson et al. (Michaelson, et al., 2012) have recently claimed that the rate 
of mutation at each site is almost perfectly predictable. They use principle 
component logistic regression fitted to a dataset of 653 de novo mutations 
(DNMs) to estimate a model from which they can predict the mutation index 
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(MI), a measure of the mutation rate, of each site in the human genome. To 
assess the fit of the model they count the number of sites in the genome with 
a particular MI (n) and the number of DNMs at those sites (d). They therefore 
have a prediction of the mutation rate from their model, the MI, and the 
observed rate of mutation, z=d/n. They find a very strong correlation between 
the logarithm of z and MI and infer that their model explains >90% of the 
variance in mutation rates. However, for each MI value they have thousands 
to millions of sites. As a consequence any variation that their model does not 
explain will tend to be averaged out when they consider the observed number 
of mutations. This can be illustrated as follows. Consider sites with an MI such 
that their mutation rate is 10-8, approximately the mean mutation rate in 
humans (1000_Genomes_Project_Consortium, 2010; Awadalla, et al., 2010; 
Conrad, et al., 2011). If the model of Michaelson et al. (Michaelson, et al., 
2012) explains all the variation in the mutation rate then all sites with this MI 
will have a mutation rate of 10-8. However, if there is unexplained variance the 
mutation rate of each site will deviate from this value. Let us assume that 
equal numbers of sites with this MI have mutation rates of 0.1 x 10-8 and 1.9 x 
10-8. It is clear that if we only sample a few sites then the observed mutation 
rate will often deviate substantially from the expected value and the 
correlation between the log of the observed number of DNMs and the MI will 
be correspondingly weak. However, as we sample more and more sites so 
the mean value will approach the expected value of 10-8 and the correlation 
between the log of the number of DNMs per site and MI will become better 
(assuming that the model of Michaelson et al. explains at least some of the 
variance). Since there are typically thousands if not millions of sites for each 
MI value, any unexplained variance will be averaged out of sight. 
 
We can estimate how much variance might be left unexplained by the model 
of Michaelson et al. (Michaelson, et al., 2012) (henceforth referred to as the 
Michaelson model) by simulating data under their model with and without 
additional variance. In the simulation we estimate the relationship between MI 
and the rate of mutation using a sets of DNMs. We then use this relationship 
to predict the expected number of mutations at a site and then simulate data 
based on these expectations (details in supplementary information).We 
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performed the analysis for three sets of DNMs: (i) the 652 DNMs reported by 
Michaelson et al. (Michaelson, et al., 2012) and used to build the model upon 
which the MI values are based (referred to as the Michaelson data), (ii) 1380 
DNMs reported by various other studies (Conrad, et al., 2011; Iossifov, et al., 
2012; Neale, et al., 2012; O'Roak, et al., 2011; Sanders, et al., 2012)(Other 
data), and (iii) 4933 DNMs reported by Kong et al. (Kong, et al., 2012)(Kong 
data)(note that only DNMs with an MI value were included).  
 
As previously shown by Michaelson et al. (Michaelson, et al., 2012), the 
correlation between the log of the number of DNMs per site and the MI value 
is very strong for the Michaelson data (r = 0.98, p<0.001; Figure 1a); this is 
perhaps not surprising given that this was the data used to construct the 
Michaelson model and the model is parameter rich. However, as Michaelson 
et al. (Michaelson, et al., 2012) showed, their model also fits the data from 
other studies well (r = 0.97, p<0.001; Figure 1b), although there is a clear non-
linearity in the relationship (a quadratic term in a non-linear regression is 
significant p = 0.010). However, the fit of the Michaelson model to the Kong 
data, which Michaelson et al. did not study, is relatively poor (r = 0.94, 
p<0.001; Figure1c). The problem would seem to lie with the Kong data, since 
the model fits the other two datasets well. The slope of the regression line 
from the Kong data (0.0047 (0.0006)) is significantly less than that observed 
for the Michaelson et al. (0.010 (0.0007)) and other datasets (0.0084 
(0.0007)) suggesting that there has been systematic under-reporting of DNMs 
from the more mutable areas of the genome in the Kong et al. dataset (or 
alternatively, that there are large numbers of false positives in the less 
mutable parts).  
 
If we assume that the Michaelson model explains all the variation in the 
mutation rate, we find that simulated datasets have similar levels of 
correlation, between the log of the number of DNMs per site and MI, to that 
observed in the real data for the Michaelson and other datasets; almost all the 
simulated correlations are stronger than the observed correlation in the Kong 
data, but this is probably because the Michaelson model clearly fits this data 
poorly. However, despite the good fit between model and data for two of the  
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datasets, we find that there could be very substantial levels of unexplained 
variance and the correlations would remain almost unaffected. Only when the 
variance associated with the unexplained variance approaches 105 do we see 
the correlations being affected and approaching the values seen in the real 
data. This level of variance dwarfs that explained by the Michaelson model; 
the coefficient of variation in the mutation rate explained by the Michaelson 
model is 1.10, the coefficient of variation for the unexplained variation is 300 if 
variance is 105. This analysis therefore shows that there could be a 
substantial amount of unexplained variance that would never be detected 
assessing model fit as Michaelson et al. have done. 
 
Assessing model fit is not easy within these datasets; there are very few 
DNMs spread across millions of sites. We therefore sought to test one 
component of mutation rate variation that is both substantial and likely to be 
difficult to predict, so called cryptic variation in the mutation rate (Hodgkinson, 
et al., 2009; Johnson and Hellmann, 2011). This is variation at the single 
nucleotide level that is independent of local sequence context. It has been 
estimated that there might be as much variation that is independent of context, 
as depends upon context (Hodgkinson, et al., 2009). The evidence for this so 
called “cryptic” variation comes from the observation that there is an excess of 
orthologous sites at which humans and chimpanzees have a SNP 
(Hodgkinson, et al., 2009; Johnson and Hellmann, 2011), and an excess 
orthologous sites at which there is a substitution between human and 
chimpanzee, and a substitution between orangutan and rhesus macaque 
(Johnson and Hellmann, 2011). The excess of coincident SNPs cannot be 
explained by ancestral polymorphism, natural selection or sequencing 
problems (Hodgkinson, et al., 2009; Johnson and Hellmann, 2011). It 
therefore appears that the excess of coincident SNPs, and substitutions at 
identical positions in different species, is due to variation in the mutation rate.  
 
To investigate whether the model of Michaelson et al. captures cryptic 
variation in the mutation rate we proceeded as follows. Leffler et al. (Leffler, et 
al., 2013) have shown, using a carefully curated dataset of human and 
chimpanzee SNPs, that there is a 16% excess of coincident SNPs at CpG 
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sites (95% confidence intervals of 14% and 17%) and a 83% (80%, 86%) 
excess at non-CpG sites between human and chimpanzee. We can use some 
theory set out Hodgkinson et al. (Hodgkinson, et al., 2009) to infer how much 
variation in the mutation rate is consistent with this excess of coincident SNPs 
and then to estimate the average mutation rate of coincident SNPs relative to 
the genomic average (see supplementary material for details). We estimate 
that sites with coincident SNPs are 1.4x (1.4x, 1.4x) and 2.7x (2.7x, 2.8x) 
more mutable than the genomic average for CpG and non-CpG sites 
respectively. How do these values compare to those under the Michaelson 
model? Under the Michaelson model we find that sites with coincident SNPs 
have significantly greater MI values at both CpG (mean MI for coincident sites 
= 91.6, non-coincident sites = 81.4; p < 0.001) and non-CpG sites (coincident 
sites = -7.77, non-coincident sites = -16.0, p<0.001). However, the differences 
in MI are small and equate to minor differences in the mutation rate predicted 
using the regression model from the Michaelson et al. data; coincident SNPs 
are predicted to be 27% more mutable at CpG and 21% more mutable at non-
CpG sites. Thus our analysis suggests that the Michaelson model captures 
much of the variation at CpG sites; the level of variation required to explain 
the excess of coincident SNPs at CpG sites is such that we would expect 
sites with coincident SNPs to be 40% more mutable than non-coincident sites 
and the Michaelson model predicts them to 27% more mutable. However, the 
Michaelson model seems to fail to capture much of the variation at non-CpG 
sites; sites with coincident SNPs are expected to be 270% more mutable than 
average sites, but the Michaelson model predicts them to be only 21% more 
mutable.  
 
The Michaelson model clearly captures some of the variation in the mutation 
rate, but how much of the variation is far from clear. It does not appear to 
capture variation in the mutation rate at non-CpG sites, which is independent 
of context, but the contribution of this variation to the overall variance in the 
mutation is also still unknown.  
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Supplementary material 
 
Materials and Methods 
Data 
 
Simulating data 
We simulated data as follows under the model of Michaelson et al. 
(Michaelson, et al., 2012) as follows. First, for a dataset of DNMs we 
regressed, using weighted regression, the log of the observed number of 
DNMs per site, z, against MI, to yield the relationship between the mutation 
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rate and MI under the Michaelson model. Since there are a limited number of 
DNMs for some MI values we binned the MI values into groups of ten, and 
removed those bins that had 5 or fewer DNMs. Using the regression equation, 
and the number of sites, we predicted the expected number of mutations at 
sites with an MI of x, Z(x). To generate data under the assumption that the 
Michaelson model explains all the variance in the mutation rate we sampled 
from a Poisson distribution with expected values Z(x). To investigate the effect 
of variance unexplained by the Michaelson model we added an additional 
step to the simulation. Having used the regression model (of log(DNMs per 
site) versus MI) to predict the expected number of mutations for a site with an 
MI of x, Z(x) we multiplied this by a random variate drawn from a lognormal 
distribution with variance = v/n, where n is the number of sites, befoe 
sampling from a Poisson distribution. The logic is as follows; the mean 
mutation rate for sites with an MI of x is Z(x), but the rate of a particular site is 
Z(x)α where α is a random variate that is lognormally distributed. Since, the 
mean of n lognormally distributed variates, each with a variance v, is itself 
approximately lognormal with a variance equal to v/n (Beaulieu, et al., 1995; 
Fenton, 1960), we can simulate the effect of unexplained variation amongst 
sites with an MI of x by multiplying the expected mutation rate by a random 
lognormal variate with variance v/n. We generated 1000 simulated datasets 
and calculated the correlation between MI and the log of the simulated 
number of mutations per site. Occasionally the simulation would generate no 
DNMs for an MI value; we removed these datasets. We then compared the 
correlation between the log of the observed number of DNMs and MI, against 
the correlation between the log of the simulated number of DNMs and MI. To 
take into account the uncertainty in the relationship between the log of the 
observed mutation rate and MI, we bootstrapped the data prior to performing 
the regression by resampling the datapoints from the regression. 
 
Coincident SNP calculation 
We investigated the difference in the mutation rate between sites with and 
without a coincident SNP as follows. We assume that the distribution of 
mutation rates is a gamma distribution arbitrarily scaled such that the mean of 
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the distribution is one; it is therefore characterized solely by its shape 
parameter. We also assume that hypermutable sites destroy themselves 
when they mutate; this seems the most likely model. This assumption makes 
little difference to the non-CpG analysis, but reduces the level of variation 
needed to explain the coincident SNPs in the CpG analysis. Hodgkinson et al. 
(Hodgkinson, et al., 2009) have shown that under this model the probability of 
observing a coincident SNP at a site is 
 
P = uhuc D(! )(e!v! ! 2 + (1! e!2v! ))d!"      (1) 
 
where uh and uc are the density of SNPs in the two species being considered, 
v is the average divergence between the species and D(γ) is the distribution of 
the rates. Therefore the average mutation rate of sites with coincident SNPs, 
relative to the average mutation rate (arbitrarily set to one) is 
 
Q =
D(! )e!v! ! 2 + (1! e!2v! )( )!" d!
D(! )e!v! ! 2 + (1! e!2v! )( )d!"
       (2) 
 
We assume that mutation rate is drawn from a gamma distribution. In our 
calculations we assume that the divergence at non-CpG sites between human 
and chimpanzee sites is 0.0092 (Chimpanzee-Sequencing-and-Analysis-
Consortium, 2005) with the divergence at CpG sites 10x higher at 0.092 
(Chimpanzee-Sequencing-and-Analysis-Consortium, 2005; Hwang and Green, 
2004). 
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v Michaelson et al. Other Kong et al. 
0 0.81 0.78 1.0 
1000 0.82 0.79 1.0 
10,000 0.81 0.76 1.0 
100,000 0.76 0.72 0.99 
500,000 0.59 0.49 0.92 
1,000,000 0.43 0.35 0.70 
2,000,000 0.25 0.17 0.36 
3,000,000 0.16 0.088 0.20 
4,000,000 0.10 0.069 0.13 
5,000,000 0.076 0.032 0.084 
 
Table 1. The proportion of simulated datasets with a greater correlation 
between the log of the number of DNMs per site and MI, than observed in the 
actual data. 
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Figure 1. The log of the number of DNMs per site versus the mutation index. 
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